Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy.
Saved in:
| Title: | Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy. |
|---|---|
| Authors: | O'Neil DS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York New York, USA dso2116@cumc.columbia.edu.; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York New York, USA., Nietz S; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of Witwatersrand, Johannesburg, Gauteng, South Africa., Buccimazza I; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Departments of Surgery and Oncology, Inkosi Albert Luthuli Central Hospital, Durban and Ngwelezane Hospital, University of KwaZulu-Natal, Empangeni, KwaZulu-Natal, South Africa., Singh U; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Departments of Surgery and Oncology, Inkosi Albert Luthuli Central Hospital, Durban and Ngwelezane Hospital, University of KwaZulu-Natal, Empangeni, KwaZulu-Natal, South Africa., Čačala S; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Departments of Surgery and Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa., Stopforth LW; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Departments of Surgery and Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa., Joffe M; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; MRC Developmental Pathways to Health Research Unit, Department of Pediatrics, University of Witwatersrand, Johannesburg, Gauteng, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand, Johannesburg, Gauteng, South Africa., Jacobson JS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York New York, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA., Neugut AI; Herbert Irving Comprehensive Cancer Center, Columbia University, New York New York, USA.; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York New York, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA., Crew KD; Herbert Irving Comprehensive Cancer Center, Columbia University, New York New York, USA.; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York New York, USA., Ruff P; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Division of Medical Oncology, Department of Medicine, University of Witwatersrand, Johannesburg, Gauteng, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand, Johannesburg, Gauteng, South Africa., Cubasch H; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.; Department of Surgery, Chris Hani Baragwanath Academic Hospital and Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand, Johannesburg, Gauteng, South Africa. |
| Source: | The oncologist [Oncologist] 2019 Jul; Vol. 24 (7), pp. 933-944. Date of Electronic Publication: 2018 Dec 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2018-0535 |
